The heavy selling pressure might have exhausted for Crown (CCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

The heavy selling pressure might have exhausted for Skyward (SKWD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

The heavy selling pressure might have exhausted for New York Times (NYT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

I rate New Oriental Education as a Hold, following my review of its results and guidance. My view of its management outlook pertaining to cash distributions and top line is unfavorable. But there are bright spots, like the educational hardware unit's growth potential and the continued focus on cost management.

Applied Digital signed a 15-year, 400 MW lease with CoreWeave worth $11 billion. Shares are up more than 35% as analysts raise targets and investors reposition APLD as a serious AI infrastructure provider.

Key Points in This Article: President Trump's decision to limit copper tariffs to semi-finished products caused a sharp price drop, impacting U.S.

U.S.-listed shares of AB InBev (BUD) sank 12% Thursday as the world's biggest beermaker's volume and sales missed estimates on soft demand in China and Brazil.

COMPASS Pathways plc (NASDAQ:CMPS ) Q2 2025 Earnings Call July 31, 2025 8:00 PM ET Company Participants Guy Goodwin - Chief Medical Officer Kabir Kumar Nath - CEO & Director Lori Englebert - Chief Commercial Officer Stephen D. Schultz - Senior Vice President of Investor Relations Steve Levine - Chief Patient Officer Teri Loxam - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Chi Wen Chin - TD Cowen, Research Division Gavin Clark-Gartner - Evercore ISI Institutional Equities, Research Division Judah C.

There is no denying that PATH has missed the first train for Agentic AI monetization, as observed in the decelerating growth hinted by the management's FY2026 guidance. With competition also heating up, it remains to be seen if PATH may report a renewed H2'25 growth opportunity through the recently released Agentic Automation in April 2025. On the other hand, PATH's market leadership in the RPA market remains compelling, significantly aided by the growing ARR and the rich cash flows.

FMC posts better-than-expected Q2 results as higher volumes offset price declines.

PTC posts a 34% fiscal Q3 2025 EPS beat and raises full-year guidance as AI tools and SaaS momentum fuel 24% revenue growth.

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

NexPoint (NREF) came out with quarterly earnings of $0.43 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.68 per share a year ago.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

While the top- and bottom-line numbers for ITT (ITT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?